LINEAGE CELL THERAPEUTICS IN (LCTX) Stock Institutional Trading Activity


LINEAGE CELL THERAPEUTICS IN (LCTX) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC and Sequoia Financial Advisors. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCBuy499,1672,404,800$4,016,016
Q3 2025Renaissance Technologies LLCSell-66,7021,905,633$3,220,520
Q2 2025Renaissance Technologies LLCSell-319,0461,972,335$1,789,697
Q1 2025Renaissance Technologies LLCBuy8,3092,291,381$1,034,788
Q4 2024Renaissance Technologies LLCBuy2,085,9722,283,072$1,147,244
Q3 2024Renaissance Technologies LLCSell-386,522197,100$178,435
Q2 2024Renaissance Technologies LLCBuy53,022583,622$582,046
Q1 2024Renaissance Technologies LLCBuy380,600530,600$785
Q4 2023Renaissance Technologies LLCBuy90,300150,000$164
Q3 2023Renaissance Technologies LLCBuy3,80059,700$70
Q2 2023Renaissance Technologies LLCBuy32,90055,900$79
Q4 2020Renaissance Technologies LLCSell-437,80623,000$40
Q3 2020Renaissance Technologies LLCSell-30,894460,806$432
Q2 2020Renaissance Technologies LLCBuy223,300491,700$428
Q1 2020Renaissance Technologies LLCBuy268,400268,400$222
Q4 2019Sequoia Financial AdvisorsBuy68,72168,721$61

Frequently asked questions about LCTX activity

  • Which institutional owners are buying LCTX?

    Institutional owners buying LCTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in LCTX activity?

    "Buy" means an investor increased their reported position in LCTX compared to the prior reporting period. This reflects growing exposure to LINEAGE CELL THERAPEUTICS IN (LCTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in LCTX increasing?

    Institutional interest in LCTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.